The bionics market has seen considerable growth due to a variety of factors.
• The bionics market has experienced rapid growth in recent years. It will grow from $13.62 billion in 2024 to $15.01 billion in 2025, with a CAGR of 10.3%.
This increase is driven by the growing number of disabilities, better healthcare infrastructure, rising healthcare expenditures, greater need for organ donors, and the rising prevalence of chronic diseases.
The bionics market is expected to maintain its strong growth trajectory in upcoming years.
• The bionics market is expected to see robust growth, reaching $21.9 billion by 2029, with a CAGR of 9.9%.
Growth drivers include a focus on customization, rehabilitation, and quality of life improvement for patients, increased public awareness and acceptance, a growing elderly population, and a rise in the geriatric demographic. Key trends include IoT integration, advancements in artificial intelligence, miniaturized wireless electronics, more sophisticated haptic and sensory technologies, and energy harvesting innovations.
The increasing prevalence of physical disabilities is expected to drive the growth of the bionics market. Physical disabilities, which affect mobility and physical tasks, are linked to conditions like arthritis, osteoporosis, and general physical degeneration. Bionic devices help improve mobility and independence for those with physical disabilities. For example, in October 2024, the UK Parliament's House of Commons Library reported that in 2022/23, 11% of children, 23% of working-age adults, and 45% of those above State Pension age in the UK had a disability, a trend that is expected to continue growing.
The bionics market covered in this report is segmented –
1) By Types: Bionic Brain, Bionic Heart, Bionic Limbs, Bionic Vision, Exoskeleton, Other Types
2) By Fixation: Implantable Bionics, External Bionics
3) By Technology: Mechanical Bionics, Electronic Bionics
4) By Application: Healthcare, Defense
Subsegments:
1) By Bionic Brain: Neural Prosthetics, Brain-Computer Interfaces (Bcis), Deep Brain Stimulation Devices
2) By Bionic Heart: Artificial Heart, Ventricular Assist Devices (Vads), Heart Valve Prostheses
3) By Bionic Limbs: Prosthetic Arms, Prosthetic Legs, Bionic Hands And Fingers
4) By Bionic Vision: Retinal Implants, Visual Prosthetics, Bionic Eyewear
5) By Exoskeleton: Lower Body Exoskeletons, Full-Body Exoskeletons, Upper Body Exoskeletons
6) By Other Types: Bionic Ears, Bionic Skin, Bionic Organs
Companies in the bionics market are introducing technological innovations such as the bionic pancreas automated insulin delivery systems to enhance diabetes management. Beta Bionics launched the iLet bionic pancreas in December 2023, which automates insulin delivery based on continuous glucose monitoring. This device simplifies diabetes management by requiring minimal user input, making it user-friendly and reducing the burden on both patients and healthcare providers.
Major companies operating in the bionics market are:
• Boston Scientific Corporation
• Zollner Elektronik AG
• Sonova Holding AG
• Ottobock SE & Co. KGaA
• Cochlear Limited
• Bioengineering Technology Inc.
• Össur hf
• Hanger Inc.
• BionX Medical Technologies Inc.
• DarioHealth Corp.
• Cyberdyne Inc.
• Syncardia Systems LLC
• AlterG Inc.
• Ekso Bionics Holdings Inc.
• MediTouch Ltd.
• ReWalk Robotics Ltd.
• Retina Implant AG
• Human Engineering
• Pixium Vision
• Second Sight Medical Products Inc.
• Bionik Laboratories Corp.
• Neuroprosthetics Ltd.
• Sierra Bionics
• Vincross Inc.
North America was the largest region in the bionics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bionics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.